… for muscle wasting, and muscle remains an under-medicated organ… muscle wasting and
summarizes novel experimental and clinical pharmacological avenues aimed at skeletal muscle…

… treatment of muscular dystrophies, in particular DMD, target the disease-causing dystrophin.
Muscle wasting is also a characteristic feature of muscle … that treatments preventing muscle …

… evidence suggests that further studies are needed before the ubiquitin proteasome system
may be definitely identified as a possible therapeutic target for muscle wasting in cancer. …

… There are currently few therapeutic options to target oxidative stress in muscle wasting (Table
2), and the full effect of reducing the oxidant burden in COPD is not completely understood…

… intracellular targets for … muscle wasting in rats treated with dexamethasone, or during sepsis
induced by caecal ligation and puncture 118 . Therefore, treatment of acute muscle wasting …

… Hormonal and/or other drug strategies that can target key steps in the molecular … maintain
muscle mass and provides an overview of some of the major conditions where muscle wasting …

… muscle wasting, although further systematic research is needed on this treatment in …
This chapter outlines several recent pharmacological approaches to inhibit muscle wasting. …

… Here, we review a few potentially promising novel therapeutic targets (Table 1). The
possibility to treat muscle wasting by anti-inflammatory treatment strategies [7, 48] as well as …

… Clinical trials testing therapeutics against muscle wasting have yielded limited success. …
patients, muscle wasting negatively influences survival by reducing tolerance of treatment and …

… treatment regimens to tackle muscle wasting and cachexia in patients with chronic diseases,
but also the muscle wasting … It is important to understand that muscle wasting is in many …